North American Interventional Cardiology Devices Market by Angioplasty Balloon & Endovascular Stent Graft - 2018 The "North American Interventional Cardiology & Peripheral Vascular Devices Market by Angioplasty Balloon (Plain/Old, Cutting), Stent (Bioabsorbable, Drug-Eluting), Catheter (IVUS, OCT), IVC Filter (Retrievable), Endovascular Stent Graft - Forecast to 2018" analyzes and studies the major market drivers, restraints, and opportunities in the U.S. and Canada. Browse 108 market data tables and 24 figures spread through 245 pages and in-depth TOC on "North American Interventional Cardiology Devices Market" http://www.marketsandmarkets.com/Market-Reports/north-american-interventional-cardiology-peripheralvascular-devices-market-138691746.html Early buyers will receive 10% customization on this report. The North American interventional cardiology devices market is expected to reach $5,947.5 million by 2018, at a meager CAGR of 2.9%. The North American interventional cardiology devices market is categorized into angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and accessory devices. Inquiry before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=138691746 A number of factors such as increasing peripheral intervention in the U.S., double digit growth in aging population, significant increase in the number of percutaneous coronary intervention (PCI) centers in the U.S., and long waiting time for care in Canada are the major drivers for the North American interventional cardiology devices market. On the other hand, declining coronary angioplasty procedures in the U.S. and conventional first level medication treatment are considered as hindrances for the growth of North American peripheral vascular devices market. Market opportunity analysis identified that rising importance of IVUS and OCT catheters in better diagnosis during angioplasty, adoption of retrievable IVC filters in peripheral artery disease treatments, and growing demand for bioabsorbable stents to minimize restenosis allow considerable scope for revenue generation in the North American interventional cardiology devices market. Buy Now: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=138691746 The notable players in the North American interventional cardiology devices market are Abbott Laboratories (U.S.), Cordis Corporation (U.S.), Medtronic, Inc. (U.S.), Boston Scientific Corporation (U.S.), and Covidien, Inc. (U.S.). Together, these companies accountedfor a share of over 90%. About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
North American Interventional Cardiology Devices Market 2018
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.